HPV Prophylaxis: Vaccines, Pap Tests, Genotyping
- Romania continues to struggle with high rates of cervical cancer cases and deaths, according to a 2024 analysis by the National Institute of Public Health.Despite the availability of...
- Cervical cancer is largely preventable through vaccination and regular screening.
- Globally, cervical cancer remains a significant health concern for women.
Romania Faces High Cervical Cancer Rates Despite Preventative Measures
Table of Contents
Published:
Romania continues to struggle with high rates of cervical cancer cases and deaths, according to a 2024 analysis by the National Institute of Public Health.Despite the availability of HPV vaccination, which offers significant protection against the disease, interest and acceptance of the vaccine remain low in the contry. A study by Save the Children romania last year also highlighted this issue.
Cervical cancer is largely preventable through vaccination and regular screening. When detected early and treated appropriately, it is often curable.
Globally, cervical cancer remains a significant health concern for women. While incidence and mortality rates have decreased in much of Europe, Romania still reports the highest figures in the European Union, according to the National Institute of Public Health.
Data from the National Cancer Prevention and Combat Plan in Romania indicates that cervical cancer is the third most common cancer among women, following breast and colorectal cancer. This differs from the broader European trend, where breast, colorectal, and bronchopulmonary cancers are the most prevalent.
2,880 New Cases, 1,177 Deaths in 2023
In 2023, Romania recorded 2,880 new cases of cervical cancer, and 1,177 women died from the disease, according to the National Institute of Public Health (INSP).
The human papillomavirus (HPV) causes more than 95% of cervical cancer cases. anti-HPV vaccination offers a high degree of protection against cervical dysplasia and cervical cancer, including both squamous cell carcinoma and adenocarcinoma. It can also protect against other cancers, including anal, oropharyngeal, vulvar, vaginal, and penile cancers.
However, HPV vaccine coverage remains low in Romania.A national vaccination program, launched in 2008, offered free vaccinations to girls between 10 and 11 years old. However, the program faced significant resistance.After a communication campaign in 2009 yielded modest results, the program was suspended for nearly a decade. It was relaunched in 2019, targeting girls aged 11-14, later extended to 11-18, with vaccinations available free of charge at family doctors’ offices with parental consent, according to the INSP.
Currently, free HPV vaccination is available for girls and boys aged 11 to 18. Women aged 19 to 45 can receive the vaccine with a 50% discount.
Many people come into contact with the HPV virus during their lives,over 80%. However, more than 90% of those who contract the virus will clear it naturally.
experts say that even infection with high-risk HPV strains does not automatically lead to cancer. It indicates an infection that requires monitoring. Monitoring protocols may change based on whether a patient has these strains. HPV genotyping, which identifies the specific HPV virus, should begin at age 30. Current guidelines recommend that women over 30 be tested for HPV in addition to the Pap test. The Pap test alone is not sufficient as patients under 30 have a high chance of naturally clearing the virus.
HPV genotyping is not widely accessible. There are calls for increased government support to make this test more readily available,as is the case in Western Europe.experts emphasize that HPV genotyping is a crucial test for women over 30.
Cervical Cancer in Romania: A Q&A Guide
Understanding the Cervical Cancer Problem in Romania
Why is cervical cancer a significant concern in Romania?
Cervical cancer poses a major health challenge for women in Romania. The country reports the highest cervical cancer rates in the European Union. Data from the National Institute of Public Health indicates that cervical cancer is the third most common cancer among women in Romania, following breast and colorectal cancer. In 2023, Romania recorded 2,880 new cases of cervical cancer and 1,177 deaths from the disease.
What causes cervical cancer?
The human papillomavirus (HPV) causes more than 95% of cervical cancer cases.
How can cervical cancer be prevented?
Cervical cancer is largely preventable through:
HPV vaccination: Offers significant protection against cervical cancer.
Regular screening: Early detection and treatment are critical.
HPV Vaccination and Prevention
What is the HPV vaccine, and how does it work?
The HPV vaccine offers a high degree of protection against cervical dysplasia and cervical cancer, including both squamous cell carcinoma and adenocarcinoma. It can also protect against other cancers, including anal, oropharyngeal, vulvar, vaginal, and penile cancers.
Who is eligible for the HPV vaccine in Romania?
Currently, as of March 25, 2025, free HPV vaccination is available in Romania for:
Girls and boys aged 11 to 18.
Women aged 19 to 45 can receive the vaccine with a 50% discount.
Why is HPV vaccination coverage low in Romania?
Low HPV vaccine coverage in Romania is an issue. There was significant resistance to earlier vaccination programs.
What is the current status of HPV vaccination programs in Romania?
A national vaccination program was launched in 2008, offering free vaccinations to girls aged 10-11. following a communication campaign in 2009, the program yielded modest results and was suspended for nearly a decade. It was relaunched in 2019, targeting girls aged 11-14 and later extended to 11-18, with vaccinations available free of charge at family doctors’ offices with parental consent.
Screening and Detection
What screening methods are used to detect cervical cancer?
The Pap test is used for cervical cancer screening. Current guidelines recommend that women over 30 be tested for HPV along with the Pap test.
What is HPV genotyping?
HPV genotyping identifies the specific HPV virus. Experts emphasize that HPV genotyping is a crucial test for women over 30.
Why is HPV genotyping important?
Even infection with high-risk HPV strains does not automatically lead to cancer. It indicates an infection that requires monitoring. HPV genotyping helps in monitoring protocols.
When should HPV genotyping begin?
HPV genotyping generally should start by age 30.
Addressing Common Concerns
What are the chances of clearing an HPV infection?
More than 80% of people come into contact with the HPV virus during their lives, and over 90% of those who contract the virus will clear it naturally.
What should I do if I have a positive HPV test result?
Consult your doctor for monitoring protocols.
Summary Table
| Feature | Details |
| :———————- | :——————————————————————————– |
| Primary Cause | Human Papillomavirus (HPV) |
| Prevention Methods | HPV Vaccination, Regular Screening |
| Vaccine Availability| Free for girls and boys aged 11-18; 50% discount for women aged 19-45 |
| Screening Methods | Pap test, HPV genotyping (recommended for women over 30) |
| Key Issue | High incidence and mortality rates, low vaccination coverage in Romania |